Literature DB >> 24122953

Ascites and serum sodium are markers of increased waiting list mortality in children with chronic liver failure.

Renata Pugliese1, Eduardo A Fonseca, Gilda Porta, Vera Danesi, Teresa Guimaraes, Adriana Porta, Irene K Miura, Cristian Borges, Helry Candido, Marcel Benavides, Flavia H Feier, Andre Godoy, Rita Antonelli Cardoso, Mario Kondo, Paulo Chapchap, Joao Seda Neto.   

Abstract

UNLABELLED: Ascites is the most common complication of cirrhosis and in adults it is associated with 50% mortality at 5 years if patients do not receive a liver transplant. The occurrence of hyponatremia in these patients has been associated with increased mortality on the waiting list. The importance of serum sodium levels and the presence of ascites in the pediatric setting remain to be clarified. A retrospective analysis of pediatric patients with cirrhosis on the transplant list was carried out between October 2000 and February 2012. The primary objective of this study was to evaluate the association of pretransplant variables with mortality within 90 days following the inclusion of patients on the waiting list. In all, 522 patients were included in the study; 345 (66%) patients were under 1 year of age; 208 (40%) of the children presented ascites. A multivariate Cox proportional hazards analysis was conducted and total bilirubin (P < 0.001, hazard ratio [HR] = 2.09, 95% confidence interval [CI] = 1.35-3.21), international normalized ratio (INR) (P < 0.001, HR = 9.83, 95% CI = 4.51-21.45), serum sodium levels (P = 0.03, HR = 0.96, 95% CI = 0.92-0.99), ascites (P = 0.001, HR = 2.59, 95% CI = 1.44-4.64), and categorized age (0-1 versus ≥ 1 year old) (P = 0.025, HR = 2.33, 95% CI = 1.11-4.86) were independently associated with risk of death in 90 days. Malnutrition (Z score height/age, weight/age) and serum albumin (pediatric endstage liver disease [PELD] formula) were not included in the final model.
CONCLUSION: The presence of ascites and serum sodium levels are important variables associated with decreased patient survival while candidates wait for a liver graft. Multicenter studies are necessary to validate these findings in order to improve current allocation policies based on the PELD score.
© 2014 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24122953     DOI: 10.1002/hep.26776

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  19 in total

1.  Justifying Nonstandard Exception Requests for Pediatric Liver Transplant Candidates: An Analysis of Narratives Submitted to the United Network for Organ Sharing, 2009-2014.

Authors:  E R Perito; H J Braun; J L Dodge; S Rhee; J P Roberts
Journal:  Am J Transplant       Date:  2017-02-28       Impact factor: 8.086

Review 2.  Cirrhosis in children and adolescents: An overview.

Authors:  Raquel Borges Pinto; Ana Claudia Reis Schneider; Themis Reverbel da Silveira
Journal:  World J Hepatol       Date:  2015-03-27

3.  A 10-Year united network for organ sharing review of mortality and risk factors in young children awaiting liver transplantation.

Authors:  Daniel H Leung; Amrita Narang; Charles G Minard; Girish Hiremath; John A Goss; Ross Shepherd
Journal:  Liver Transpl       Date:  2016-11       Impact factor: 5.799

4.  ABO-incompatible deceased donor pediatric liver transplantation: Novel titer-based management protocol and outcomes.

Authors:  Krupa R Mysore; Ryan W Himes; Abbas Rana; Jun Teruya; Moreshwar S Desai; Poyyapakkam R Srivaths; Kimberly Zaruca; Andrea Calvert; Danielle Guffey; Charles G Minard; Eda Morita; Lisa Hensch; Michael Losos; Vadim Kostousov; Shiu-Ki Rocky Hui; Jordan S Orange; John A Goss; Sarah K Nicholas
Journal:  Pediatr Transplant       Date:  2018-08-02

Review 5.  The Kidney in Pediatric Liver Disease.

Authors:  Robyn Greenfield Matloff; Ronen Arnon
Journal:  Curr Gastroenterol Rep       Date:  2015-09

Review 6.  Beyond the Pediatric end-stage liver disease system: solutions for infants with biliary atresia requiring liver transplant.

Authors:  Mary Elizabeth M Tessier; Sanjiv Harpavat; Ross W Shepherd; Girish S Hiremath; Mary L Brandt; Amy Fisher; John A Goss
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

7.  Nonstandard Exception Requests Impact Outcomes for Pediatric Liver Transplant Candidates.

Authors:  H J Braun; E R Perito; J L Dodge; S Rhee; J P Roberts
Journal:  Am J Transplant       Date:  2016-06-27       Impact factor: 8.086

8.  Random forest analysis identifies change in serum creatinine and listing status as the most predictive variables of an outcome for young children on liver transplant waitlist.

Authors:  Sakil Kulkarni; Lisa Chi; Charles Goss; Qinghua Lian; Michelle Nadler; Janis Stoll; Maria Doyle; Yumirle Turmelle; Adeel Khan
Journal:  Pediatr Transplant       Date:  2020-11-24

Review 9.  Advances in management of end stage liver disease in children.

Authors:  Aradhana Aneja; Elizabeth Scott; Rohit Kohli
Journal:  Med J Armed Forces India       Date:  2021-03-25

10.  Impact of hyponatremia on frequency of complications in patients with decompensated liver cirrhosis.

Authors:  Ashraf Abd El-Khalik Barakat; Amna Ahmed Metwaly; Fatma Mohammad Nasr; Maged El-Ghannam; Mohamed Darwish El-Talkawy; Hoda Abu Taleb
Journal:  Electron Physician       Date:  2015-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.